Does the angiotensin-converting enzyme (ACE)/ACE2 balance contribute to the fate of angiotensin peptides in programmed hypertension?
Brosnihan
K Bridget
KB
Neves
Liomar A A
LA
Chappell
Mark C
MC
D000085962:Angiotensin-Converting Enzyme 2; D000809:Angiotensins / Q000378:metabolism*; D000818:Animals; D002268:Carboxypeptidases / Q000378:metabolism*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000209:etiology* / Q000378:metabolism*; D010446:Peptide Fragments / Q000378:metabolism; D007703:Peptidyl-Dipeptidase A / Q000378:metabolism*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D039401:Prenatal Nutritional Physiological Phenomena
D000809:Angiotensins; D010446:Peptide Fragments; D002268:Carboxypeptidases; D007703:Peptidyl-Dipeptidase A; C000705307:ACE2 protein, human; D000085962:Angiotensin-Converting Enzyme 2